Hasan Ashraf is a Cardiology physician affiliated with Christus Health. OpenAlex indexes 115 publications with 2,379 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2401 S 31st St
Temple, TX 765080001
Telephone
254-724-2111Provider last certified this registry record 21 Jan 2026.
Clinical trials
- Randomized Controlled Trial (RCT) in Children With Severe Pneumonia
Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20251 payment
- Biosense Webster, Inc.Program year20241 payment
- Boston Scientific CorporationProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.8%Beta blocker37.9%Metoprolol Succinate33%Sotalol28%Carvedilol22%Metoprolol Tartrate14%Sotalol Af3%Part D<11 patientsAntiarrhythmic15.4%Amiodarone Hcl63%Mexiletine Hcl25%Flecainide Acetate12%Part D<11 patients+ 5 more classes in this area
Blood & clotting
18.9%Factor Xa inhibitor17.6%Eliquis100%Part D≥41 patientsP2Y12 inhibitor1.3%Clopidogrel100%Part D<11 patientsAnti-infectives
6.8%First-generation cephalosporins6.8%Cephalexin100%Part D≥60 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prediction of permanent pacemaker implantation after transcatheter aortic valve replacement: The role of machine learning
World Journal of Cardiology
2023 - Long-Term Clinical Outcomes of Underdosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Atrial Flutter
The American Journal of Medicine
2021 - Does the Age of Sudden Cardiac Death in Family Members Matter in Brugada Syndrome?
Journal of the American Heart Association
2021 - Use of Flecainide in Stable Coronary Artery Disease: An Analysis of Its Safety in Both Nonobstructive and Obstructive Coronary Artery Disease
American Journal of Cardiovascular Drugs
2021 - Artificial Intelligence Trumps TAVI2-SCORE and CoreValve Score in Predicting 1-Year Mortality Post-Transcatheter Aortic Valve Replacement
Cardiovascular revascularization medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”